Asia Spotlight: Roche's Joe McCracken On Early-stage Partnering In Asia
Executive Summary
On the second Monday of each month, "The Pink Sheet" provides exclusive news and commentary on the Asia biopharma market from the editors of its affiliated online publication, PharmAsia News. Register at 1http://pharmasianews.elsevierbi.com/PAN_Trial_LP.html for a free trial.
You may also be interested in...
Roche, OrbiMed And McKinsey's Entrepreneurship Competition Builds Platform For China's Young Biotech Community
SHANGHAI - Seeking ways to tap into China's rich talent pool and spark local innovation, Roche, OrbiMed and McKinsey are hoping a SEED business competition can nurture entrepreneurs in China's biotech academic community
China's Escalating Scientific Output Tempered By Quality Concerns
TOKYO - Much ink has been devoted to cover the explosion of scientific research being developed in China, but some in the pharma industry charged with identifying potential research partners are troubled with the quality of some research coming out of China
Roche Signs First In-licensing Deal In Korea With DigitalBiotech For Alzheimer's Disease Candidate
SEOUL - South Korea's DigitalBiotech signed a research collaboration and license option agreement with Roche covering DigitalBiotech's proprietary RAGE antagonist program targeting Alzheimer's disease